<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02968355</url>
  </required_header>
  <id_info>
    <org_study_id>SDY-017266</org_study_id>
    <secondary_id>HHSN272201600002C</secondary_id>
    <secondary_id>W911QY-13-D-0080</secondary_id>
    <nct_id>NCT02968355</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the FilmArray® Global Fever (GF) Panel</brief_title>
  <official_title>Clinical Evaluation of the FilmArray® Global Fever (GF) Panel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioFire Defense LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>BioFire Defense LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the clinical sensitivity and specificity of the FilmArray Global
      Fever (GF) Panel.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The FilmArray Global Fever (GF) Panel, developed by BioFire Defense in collaboration with the
      U.S. Department of Defense and NIAID, uses an automated, multiplex PCR system to evaluate
      whole blood samples for 19 pathogens simultaneously in under an hour. Targets of the GF Panel
      are Chikungunya virus, CCHF virus, dengue virus (serotypes 1-4), Ebolavirus, Lassa virus,
      Marburgvirus, West Nile virus, Yellow fever virus, Zika virus, Bacillus anthracis,
      Francisella tularensis, Leptospira spp., Salmonella enterica serovar Typhi and Paratyphi A,
      Yersinia pestis, Leishmania donovani complex, Plasmodium spp., P. falciparum, and P.
      ovale/vivax. BioFire Defense is conducting a prospective clinical study to evaluate the
      sensitivity and specificity of the GF Panel when used to test blood collected from subjects
      with fever or who have recently had fever. This multi-center study is being conducted at
      locations around the world.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical sensitivity and specificity of the FilmArray Global Fever (GF) Panel</measure>
    <time_frame>18 months</time_frame>
    <description>Percent Positive Agreement and Percent Negative Agreement between FilmArray Result and Comparator Assay</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>Subjects/Specimens</arm_group_label>
    <description>Subjects/Specimens that meet the eligibility criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational study</intervention_name>
    <description>Observational study</description>
    <arm_group_label>Subjects/Specimens</arm_group_label>
    <other_name>FilmArray</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood specimen may be retained at the participating clinical sites for future use.
      Specimen nucleic acid may be retained at BioFire and participating clinical sites for future
      performance evaluations of the FilmArray.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with fever will be prospectively enrolled, and whole blood will be collected.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Whole blood in EDTA (prospectively collected via informed consent)

          -  Subject has a recorded or self-reported fever within the past two days.

          -  Subject has not participated in the study within the last 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia Phillips, Ph. D.</last_name>
    <role>Study Director</role>
    <affiliation>BioFire Defense LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cynthia Andjelic, Ph. D.</last_name>
    <phone>801-262-3592</phone>
    <phone_ext>1173</phone_ext>
    <email>Cynthia.Andjelic@BioFireDefense.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aileen Chang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chris Mores, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Naval Medical Research Unit Two</name>
      <address>
        <city>Phnom Penh</city>
        <country>Cambodia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>United States Army Medical Research Directorate Georgia</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamar Akhvlediani, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Naval Medical Research Unit Three</name>
      <address>
        <city>Navrongo</city>
        <country>Ghana</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universidad Nacional Autonoma de Honduras</name>
      <address>
        <city>Tegucigalpa</city>
        <state>Central District</state>
        <country>Honduras</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>United States Army Medical Research Directorate Kenya</name>
      <address>
        <city>Kisumu</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Naval Medical Research Unit Six</name>
      <address>
        <city>Iquitos</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kilimanjaro Christian Medical Centre</name>
      <address>
        <city>Moshi</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Armed Forces Research Institute of Medical Sciences</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Infectious Diseases Institute</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Cambodia</country>
    <country>Georgia</country>
    <country>Ghana</country>
    <country>Honduras</country>
    <country>Kenya</country>
    <country>Peru</country>
    <country>Tanzania</country>
    <country>Thailand</country>
    <country>Uganda</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>India</country>
  </removed_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 16, 2016</study_first_submitted>
  <study_first_submitted_qc>November 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

